ID: ALA4551298

Max Phase: Preclinical

Molecular Formula: C27H23N5O3S2

Molecular Weight: 529.65

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)Nc1c(Cc2cccc3ccccc23)cc(=O)n2c1SCC2c1nc(-c2ccccc2)n[nH]1

Standard InChI:  InChI=1S/C27H23N5O3S2/c1-37(34,35)31-24-20(14-19-12-7-11-17-8-5-6-13-21(17)19)15-23(33)32-22(16-36-27(24)32)26-28-25(29-30-26)18-9-3-2-4-10-18/h2-13,15,22,31H,14,16H2,1H3,(H,28,29,30)

Standard InChI Key:  UNBJKSGVXOURAI-UHFFFAOYSA-N

Associated Targets(Human)

HeLa 229 50 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chlamydia trachomatis 699 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 529.65Molecular Weight (Monoisotopic): 529.1242AlogP: 4.44#Rotatable Bonds: 6
Polar Surface Area: 109.74Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.91CX Basic pKa: 1.65CX LogP: 4.34CX LogD: 4.23
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.34Np Likeness Score: -1.02

References

1. Kulén M, Núñez-Otero C, Cairns AG, Silver J, Lindgren AEG, Wede E, Singh P, Vielfort K, Bahnan W, Good JAD, Svensson R, Bergström S, Gylfe Å, Almqvist F..  (2019)  Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone based Chlamydia trachomatis inhibitors.,  10  (11): [PMID:32206238] [10.1039/C9MD00405J]

Source